This different and apparently contrasting behavior of β-lapachone seems to be attributable to the preferential accumulation of ROS species via this compound in NQO1-overexpressing cancers, but not in normal cells (that are protected by low NQO1 expression and by high catalase levels). This evidence concerns the gene NQO1 and cancer.